NDC 70710-2007-03 - Deflazacort Oral Suspension
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-2007
- Requested NDC
- 70710-2007-03
- Package NDCs from labels
- 70710-2007-3, 70710-2007-03
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc. | Zydus Lifesciences Global FZE | Doppel Farmaceutici S.r.l.
- Effective date
- 2026-11-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Deflazacort Oral Suspension | Zydus Pharmaceuticals (USA) Inc. | Zydus Lifesciences Global FZE | Doppel Farmaceutici S.r.l. | 2026-11-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-2007-3 | Deflazacort Oral Suspension | 13 mL in 1 BOTTLE | SUSPENSION | 13 | 2 | |
| 70710-2007-3 | Deflazacort Oral Suspension | 1 in 1 CARTON | SUSPENSION | 1 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70710-2007-3 | ML - Milliliter | 70710-2007 | 40ccc302-cbc6-450e-8d85-a62dcaa86388 | 1 | 2026-01-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Medics Choice Fresh and Soothe | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | KC Pharmaceuticals, Inc. | 3bc03d54-6b31-5921-e063-6294a90af599 | 2025-08-01 | Warnings | K679OBS311 |
| Focus Tears PF | CARBOXYMETHYLCELLULOSE SODIUM | Covalent Medical | 772c7070-82ff-4371-b071-940ff91372c6 | 2025-07-17 | Warnings | K679OBS311 |
| KYMBEE | DEFLAZACORT | Upsher-Smith Laboratories, LLC | 89365f9f-a7ae-40d3-aecc-e4add75d21c2 | 2025-07-17 | Warnings, Adverse reactions | KR5YZ6AE4B |
| Aller-Chord F | ACETALDEHYDE, ACETICUM AC, ARG NIT, CAFFEINUM, CALC SULPH, CITRICUM AC, CORTISONE ACETICUM, ECHINACEA PURP, FOLLICULINUM, FRAGARIA, FUMARICUM AC, GALLICUM AC, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRANGEA, LAC VAC, LECITHIN, LIMULUS, LYCOPERSICUM, LYCOPODIUM, NAT BICARB, NAT MUR, NUX VOM, PARAFFINUM, PHOSPHORICUM AC, SACCHARUM OFF, SILICEA, TARTARICUM AC, TORULA CEREVISIAE. | Energetix Corporation | ff4eb7b2-8272-4bd3-99a9-7e589b30d59a | 2025-07-15 | Warnings | Q40Q9N063P |
| DENTAL-CHORD | ACETICUM ACIDUM, AMMONIUM MURIATICUM, ARGENTUM METALLICUM, AURUM METALLICUM, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CARBOLICUM ACIDUM, CITRUS LIMONUM, CUPRUM METALLICUM, FERRUM METALLICUM, GLYCYRRHIZA GLABRA, LAPPA MAJOR, MEDULLA OSSIS SUIS, MERCURIUS SOLUBILIS, MYRRHA, NATRUM FLUORATUM, PALLADIUM METALLICUM, PHOSPHORICUM ACIDUM, PHYTOLACCA DECANDRA, SELENIUM METALLICUM, SILICEA, STANNUM METALLICUM, STAPHYSAGRIA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, X-RAY, ZINCUM OXYDATUM | Energetix Corporation | 6c9ba926-7c35-49fd-94d8-988ca0bb772c | 2025-07-15 | Warnings | Q40Q9N063P |
| PYQUVI | DEFLAZACORT | Aucta Pharmaceuticals, Inc. | 39854f19-d8be-6438-e063-6394a90a9422 | 2025-07-09 | Warnings, Adverse reactions | 1870964 KR5YZ6AE4B |
| Hydrocortisone and Acetic Acid | HYDROCORTISONE AND ACETIC ACID | Sun Pharmaceutical Industries, Inc. | 6383c722-84e2-4719-a13d-19c54e3eefff | 2025-07-07 | Warnings, Adverse reactions | Q40Q9N063P |
| Deflazacort | DEFLAZACORT | Amneal Pharmaceuticals NY LLC | 18518568-a40b-41cb-91ce-44fbb5557971 | 2025-06-16 | Warnings, Adverse reactions | KR5YZ6AE4B |
| hydrocortisone and acetic acid | HYDROCORTISONE AND ACETIC ACID OTIC | Saptalis Pharmaceuticals, LLC | d9a3597c-2c9d-46cc-818b-8bb3aa5c4f32 | 2025-04-25 | Warnings, Adverse reactions | Q40Q9N063P |
| Acetic Acid | ACETIC ACID | NuCare Pharmaceuticals,Inc. | f9b4d18b-25f3-604f-e053-6394a90a5531 | 2025-02-10 | Warnings, Adverse reactions | Q40Q9N063P |
| Endopan HP | ACETICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, BRYONIA (ALBA), CHROMIUM, COLCHICUM AUTUMNALE, LACTICUM ACIDUM, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SULPHUR, SYZYGIUM JAMBOLANUM, THUJA OCCIDENTALIS, URANIUM NITRICUM | Energique, Inc. | 2bc69a24-c24c-4d12-92bb-7c073edf90dc | 2025-01-24 | Warnings | Q40Q9N063P |
| Lubricating Tears | CARBOXYMETHYLCELLULOSE SODIUM 0.5% SOLUTION | Reliable 1 Laboritories LLC | 29023a57-eba3-4241-e063-6294a90a7048 | 2025-01-15 | Warnings | K679OBS311 |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a2b9456-8ca0-8253-e053-2a95a90a8f12 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a2a34f9-ed95-9921-e053-2995a90a0d59 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a2bc45d-e0c8-3af2-e053-2a95a90af0f1 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a67169d-6b15-3406-e053-2995a90a60e4 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a673225-27be-040a-e053-2a95a90a0a98 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a66b61d-82bd-2bbb-e053-2995a90a0b58 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a677063-09d2-8052-e053-2a95a90affae | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a678fac-289c-0f5c-e053-2995a90a0f43 | 2025-01-09 | Q40Q9N063P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.